Diagnostic Approach to Canine Immune-Mediated Hemolytic Anemia: From Clinical Suspicion to Diagnostic Confirmation

Diagnosing immune-mediated hemolytic anemia (IMHA) requires more than identifying anemia on a complete blood count. Since several conditions can produce hemolysis, confirmation of IMHA depends on demonstrating evidence of immune-mediated erythrocyte destruction while simultaneously identifying signs of hemolysis. A systematic diagnostic approach helps veterinarians distinguish IMHA from other causes of anemia and supports appropriate therapeutic planning. Immunological assays, blood smear evaluation, and assessment of hemolytic indicators together form the cornerstone of diagnosis¹. 

Establishing Evidence of Immune-Mediated Erythrocyte Destruction 

The primary objective of immunological testing is to detect anti-erythrocyte antibodies attached to the surface of red blood cells. Several diagnostic tests are available, each contributing supportive evidence toward the diagnosis of IMHA. 

Spontaneous Agglutination Test 

In dogs with a high concentration of anti-erythrocyte antibodies, red blood cells may undergo spontaneous agglutination. This appears as visible clumping of erythrocytes in EDTA-anticoagulated blood and reflects significant antibody loading on the RBC surface. However, because spontaneous agglutination generally occurs only in severe disease, the test has limited sensitivity and should not be used as the sole diagnostic criterion. 

Saline Agglutination Test (SAT) 

The saline agglutination test remains one of the most commonly used bedside tests when IMHA is suspected. 

The procedure involves mixing one drop of EDTA-anticoagulated blood with two drops of 0.9% saline on a glass slide, followed by gentle mixing and evaluation for macroagglutination. Persistence of erythrocyte clumping after saline dilution supports antibody-mediated agglutination². 

Microscopic examination is essential because rouleaux formation may resemble true agglutination. True autoagglutination appears as irregular "clusters of grapes," whereas rouleaux resembles a "stack of coins." If differentiation remains uncertain, additional saline dilution (1:3) or comparison with a diluted control sample can improve interpretation. Importantly, a negative SAT does not exclude IMHA, as autoagglutination is generally associated with high antibody titres. 

Direct Antiglobulin (Coombs') Test 

The direct antiglobulin test (DAT), commonly known as the Coombs' test, is widely used to detect antibodies bound to erythrocyte membranes². 

The procedure includes preparation of a 5% RBC suspension, repeated washing with saline or phosphate-buffered saline, followed by incubation with Coombs' reagent. Agglutination observed after incubation indicates the presence of erythrocyte-bound immunoglobulins². 

Although DAT is an established diagnostic tool, several limitations should be recognized. False-negative results may occur, and the test requires relatively large quantities of antisera, making it comparatively expensive in some settings¹. 

Flow Cytometry 

Flow cytometry offers a quantitative method for detecting membrane-bound immunoglobulins on erythrocytes¹. 

In this technique, erythrocyte-bound antibodies are labelled using fluorescein-conjugated antiglobulin, allowing fluorescence intensity to be measured objectively. Compared with DAT, flow cytometry requires smaller sample volumes and reduced quantities of antisera while providing quantitative assessment of antibody binding¹. 

Osmotic Fragility Test 

Dogs with IMHA often exhibit increased erythrocyte osmotic fragility, making this test an additional diagnostic aid³. 

When erythrocytes from affected dogs are placed in a hypotonic solution, spherocytes undergo hemolysis more rapidly than normal erythrocytes because of their reduced surface area-to-volume ratio. Although the rapid osmotic fragility test is simple and less labour-intensive, its diagnostic value has not yet been fully established³. 

Interpreting the Overall Diagnostic Picture 

No single diagnostic test should be interpreted in isolation. Diagnosis becomes stronger when laboratory evidence of immune-mediated erythrocyte destruction is combined with indicators of ongoing hemolysis. 

According to the ACVIM diagnostic approach, IMHA can be categorized as follows¹: 

• Definitive IMHA: At least two indicators of immune-mediated destruction (positive slide agglutination, positive DAT, or spherocytes) together with at least one indicator of hemolysis such as jaundice, hyperbilirubinemia, bilirubinuria, hemoglobinemia, or hemoglobinuria.

• Supportive of IMHA: Several indicators of immune-mediated destruction or hemolysis are present but do not fulfill all criteria for definitive diagnosis.

• Suspicious for IMHA: One indicator of immune-mediated destruction is present without accompanying evidence of hemolysis.

This structured approach helps standardize diagnostic interpretation and reduces diagnostic uncertainty¹. 

Practical Clinical Insights 

• Approach suspected IMHA cases by combining clinical findings with laboratory evidence rather than relying on a single diagnostic test.

• Perform microscopic evaluation whenever agglutination is observed to distinguish true autoagglutination from rouleaux formation.

• Remember that a negative saline agglutination test does not rule out IMHA, particularly in dogs with lower antibody titres.

• Interpret Coombs' test results alongside blood smear findings and indicators of hemolysis to improve diagnostic confidence.

• Applying the ACVIM diagnostic framework can help categorize cases consistently and support clinical decision-making¹. 

 Conclusion 

Diagnosing canine IMHA requires integration of immunological testing with evidence of hemolysis and careful interpretation of laboratory findings. Spontaneous agglutination testing, saline agglutination testing, the direct antiglobulin test, flow cytometry, and osmotic fragility testing each contribute valuable diagnostic information when interpreted in the appropriate clinical context. A systematic approach based on multiple diagnostic indicators improves diagnostic confidence and supports timely management of dogs with suspected immune-mediated hemolytic anemia. 

References 

1. Garden OA, Kidd L, Mexas AM, Chang YM, Jeffery U, Blois SL, Fogle JE, MacNeill AL, Lubas G, Birkenheuer A, Buoncompagni S. ACVIM consensus statement on the diagnosis of immune-mediated hemolytic anemia in dogs and cats. Journal of veterinary internal medicine. 2019 Mar;33(2):313-34. https://academic.oup.com/jvim/article-pdf/33/2/313/66658972/jvim15441.pdf 

2. Karthik I, Dubey A, Swamy M, Verma Y, Jatav M, Khare A, Rakesh S. Immune mediated hemolytic anemia in dogs–an overview. Indian J Agric Allied Sci. 2022;8(4) https://www.researchgate.net/publication/377525778 

3. Paes G, Paepe D, Meyer E, Kristensen AT, Duchateau L, Campos M, Daminet S. The use of the rapid osmotic fragility test as an additional test to diagnose canine immune-mediated haemolytic anaemia. Acta Veterinaria Scandinavica. 2013 Oct 25;55(1):74. https://link.springer.com/content/pdf/10.1186/1751-0147-55-74.pdf